Loading...
Market
What will be the parental acceptance rate of genomic sequencing in newborn screening by the end of 2025?
3
Resolution / Starting Odds
0-50% • 25%
51-75% • 25%
76-90% • 25%
91-100% • 25%
Surveys conducted by health organizations or academic studies
Story
GUARDIAN Study Shows 99.6% Success in Newborn Genome Sequencing, Identifying 110 True Positives Including Severe Combined Immunodeficiency
Oct 24, 2024, 03:15 PM
The GUARDIAN study has revealed significant advancements in newborn screening through the integration of genomic sequencing. The study demonstrated a 99.6% sequencing success rate using dried blood spots, allowing for the identification of 110 true positives that traditional screening methods missed. This early detection enabled timely interventions for critical conditions such as severe combined immunodeficiency and long QT syndrome. The findings suggest that incorporating genome sequencing into standard newborn screening could enhance rare disease diagnosis and improve health outcomes for newborns. Additionally, the study reported high parental acceptance, indicating a favorable outlook for broader implementation of genomic screening practices.
View original story
Similar markets
More than 50% • 25%
25% to 50% • 25%
10% to 25% • 25%
Less than 10% • 25%
0-25% • 33%
26-50% • 33%
51-100% • 34%
Yes • 50%
No • 50%
Less than 10% • 25%
10% to 30% • 25%
30% to 50% • 25%
More than 50% • 25%
Majority Support • 25%
Majority Oppose • 25%
Evenly Split • 25%
No Clear Opinion • 25%
0-10 hospitals • 33%
11-20 hospitals • 33%
21+ hospitals • 34%
Yes, all major clinics • 25%
Yes, more than half • 25%
Yes, less than half • 25%
No • 25%
Less than 1% • 25%
1% to 5% • 25%
5% to 10% • 25%
More than 10% • 25%
1-5 articles • 33%
6-10 articles • 33%
11+ articles • 34%
Yes • 50%
No • 50%
0-10% • 25%
11-25% • 25%
26-50% • 25%
51%+ • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%